GlassScriptPhysician profile
Zaneta Pabon
NPI 1730660747
$1,013.20
in general payments reported to CMS, 2019-2025
10 companies · $166 in 2025
The $166 reported for 2025 was less than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $79.86 · 2023: $493 · 2024: $273 · 2025: $166.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $933.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $933.34 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $430.01 | 2023-2025 | |
| Merz North America, INC. | $347.99 | 2023-2024 | Xeomin |
| Mentor Worldwide LLC | $53.07 | 2023-2024 | Mentor Memorygel Resterilizable Gel Sizer, Artoura Breast Tissue Expander |
| Integra Lifesciences Corporation | $44.94 | 2023-2024 | Integra, Durasorb Monofilament Mesh, Integra Dermal Regeneration Template |
| Bioventus LLC | $36.19 | 2022 | |
| Kci USA, INC. | $26.44 | 2022 | |
| Kerecis Limited | $21.84 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Smith+Nephew, INC. | $20.68 | 2024 | Pico 7 |
| Checkpoint Surgical, INC | $17.23 | 2022 | |
| Vertex Pharmaceuticals Incorporated | $14.81 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Zaneta Pabon listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.